Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07459686

An Observational Study to Learn About Velsipity After Long Term Use in Patients With Ulcerative Colitis

Sponsor: Pfizer

View on ClinicalTrials.gov

Summary

A study to assess the safety and effectiveness of Velsipity Tablets 2 mg during long-term treatment (up to a maximum of 52 weeks) in patients with ulcerative colitis under actual medical practice.

Official title: Velsipity® Tablets 2 mg Special Investigation (Investigation on Long-Term Use in Patients With Ulcerative Colitis)

Key Details

Gender

All

Age Range

0 Years - Any

Study Type

OBSERVATIONAL

Enrollment

553

Start Date

2026-03-31

Completion Date

2029-01-29

Last Updated

2026-03-10

Healthy Volunteers

No

Interventions

DRUG

Velsipity

2 milligrams(mg) tablet as provided in real world practice